巨春蓉, 徐鑫, 薛武军. 实体器官移植受者感染新型冠状病毒的诊疗策略[J]. 器官移植, 2023, 14(2): 183-193. DOI: 10.3969/j.issn.1674-7445.2023.02.002
引用本文: 巨春蓉, 徐鑫, 薛武军. 实体器官移植受者感染新型冠状病毒的诊疗策略[J]. 器官移植, 2023, 14(2): 183-193. DOI: 10.3969/j.issn.1674-7445.2023.02.002
Ju Chunrong, Xu Xin, Xue Wujun. Diagnosis and treatment strategies for solid organ transplant recipients with SARS-CoV-2 infection[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 183-193. DOI: 10.3969/j.issn.1674-7445.2023.02.002
Citation: Ju Chunrong, Xu Xin, Xue Wujun. Diagnosis and treatment strategies for solid organ transplant recipients with SARS-CoV-2 infection[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 183-193. DOI: 10.3969/j.issn.1674-7445.2023.02.002

实体器官移植受者感染新型冠状病毒的诊疗策略

Diagnosis and treatment strategies for solid organ transplant recipients with SARS-CoV-2 infection

  • 摘要: 实体器官移植受者(SOTR)由于长期服用免疫抑制药,属于各种病原体感染的高危人群,包括新型冠状病毒(新冠病毒)。另外,SOTR往往伴有高血压、糖尿病等慢性基础疾病,感染新冠病毒后重型率和病死率高于普通人群,因此得到移植领域专家的高度重视。奥密克戎株目前为全球范围内的主要流行毒株,快速扩散至全球100多个国家,引起广泛关注。根据最新的国际关于新冠病毒感染诊治指南和我国相关专家共识,结合目前新冠病毒感染疫情形势及我国《新型冠状病毒感染诊疗方案(试行第十版)》,本文从新冠病毒感染的流行病学、临床表现和预后、诊断和临床分型以及治疗方面进行简单述评。

     

    Abstract: Due to long-term use of immunosuppressive agents, solid organ transplant recipients (SOTR) belong to high-risk populations of multiple pathogenic infection, including SARS-CoV-2. In addition, SOTR are constantly complicated by chronic diseases, such as hypertension and diabetes mellitus, etc. After infected with SARS-CoV-2, the critically ill rate and fatality of SOTR are higher than those of the general population, which captivates widespread attention from experts in the field of organ transplantation. Omicrone variant is currently the significant pandemic strain worldwide, rapidly spreading to more than 100 countries worldwide and causing broad concern. According to the latest international guidelines on the diagnosis and treatment of SARS-CoV-2 infection and relevant expert consensus in China combined with current domestic situation of SARS-CoV-2 pandemic and China's "diagnosis and treatment regimen for SARS-CoV-2 infection (Trial Version 10)", the epidemiology, clinical manifestations and prognosis, diagnosis, clinical classification and treatment of SARS-CoV-2 infection were briefly reviewed.

     

/

返回文章
返回